<DOC>
	<DOC>NCT01216410</DOC>
	<brief_summary>The study investigates the incidence of intraoperative nausea and vomiting under spinal anesthesia using a phenylephrine infusion with and without prophylactic antiemetics.</brief_summary>
	<brief_title>Prevention of Intraoperative Nausea and Vomiting During Cesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>English speaking ASA III nonlaboring women with single gestations â‰¥36 weeks Scheduled or unscheduled cesarean delivery under spinal anesthesia Height: 5 feet5 feet 11 in. Laboring women needing an emergency cesarean delivery Subjects less than 18 years of age Receipt of a drug with antiemetic properties in the 24 hours prior to cesarean section Allergy to ondansetron, or metoclopramide Severe hypertensive disease of pregnancy defined as systolic blood pressure (SBP)&gt;160mmHg, diastolic blood pressure (DBP)&gt;110mmHg requiring antihypertensive treatment or associated with significant proteinuria. Severe Cardiac disease in pregnancy with marked functional limitations Diabetes type I Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants Morbid obesity (body mass index (BMI)&gt;45) Inclusion in another anesthetic study involving drug administration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
</DOC>